Genentech and Amgen Cease Fire on Biosimilar Litigation
July 9, 2020
Tony Hagen
The Center for Biosimilars
Axinn partner Ted Mathias was quoted in The Center for Biosimilars article, "Genentech and Amgen Cease Fire on Biosimilar Litigation."
Click here to access the article.